Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides

J K Taylor1, Q Q Zhang, J R Wyatt

  • 1Department of Pharmacology, Isis Pharmaceuticals, Carlsbad, CA 92008, USA.

Nature Biotechnology
|November 5, 1999
PubMed

Insights

This study shows that altering the ratio of Bcl-xL to Bcl-xS proteins using antisense oligonucleotides can sensitize cancer cells to apoptosis. This approach offers a new strategy for enhancing chemotherapy and radiation treatment effectiveness.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Apoptosis resistance is a key challenge in chemotherapy for tumors.
  • The balance of antiapoptotic (e.g., Bcl-xL) and proapoptotic (e.g., Bcl-xS) proteins regulates apoptosis.
  • Alternative splicing of the bcl-x gene produces these antagonistic proteins.

Purpose of the Study:

  • To investigate if manipulating the Bcl-xL/Bcl-xS ratio can sensitize cells to apoptosis.
  • To demonstrate the efficacy of antisense oligonucleotides in altering splice site selection for therapeutic potential.

Main Methods:

  • Utilized antisense oligonucleotides to target and modify the alternative splicing of the bcl-x gene.
  • Exposed treated cells to ultraviolet B radiation and chemotherapeutic drugs.
  • Assessed cellular sensitivity to apoptosis.

Main Results:

  • Altering the Bcl-xL to Bcl-xS ratio via antisense oligonucleotides sensitized cells to apoptosis.
  • This sensitization was observed in response to both ultraviolet B radiation and chemotherapy.
  • Demonstrated successful modification of splice site selection for an endogenous gene.

Conclusions:

  • Antisense oligonucleotides can effectively modulate the Bcl-xL/Bcl-xS ratio, impacting cell survival.
  • This strategy represents a powerful tool for regulating apoptosis and potentially overcoming chemotherapy resistance.
  • The findings highlight a novel therapeutic approach for enhancing cancer treatment outcomes.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying DNA...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...